These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 36744346)
21. Imaging brain iron and diffusion patterns: a follow-up study of Parkinson's disease in the initial stages. Rossi ME; Ruottinen H; Saunamäki T; Elovaara I; Dastidar P Acad Radiol; 2014 Jan; 21(1):64-71. PubMed ID: 24331266 [TBL] [Abstract][Full Text] [Related]
22. Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease. Du G; Lewis MM; Styner M; Shaffer ML; Sen S; Yang QX; Huang X Mov Disord; 2011 Aug; 26(9):1627-32. PubMed ID: 21618607 [TBL] [Abstract][Full Text] [Related]
23. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease? Duncan GW; Firbank MJ; Yarnall AJ; Khoo TK; Brooks DJ; Barker RA; Burn DJ; O'Brien JT Mov Disord; 2016 Jan; 31(1):103-10. PubMed ID: 26202802 [TBL] [Abstract][Full Text] [Related]
24. Hemisphere, gender and age-related effects on iron deposition in deep gray matter revealed by quantitative susceptibility mapping. Gong NJ; Wong CS; Hui ES; Chan CC; Leung LM NMR Biomed; 2015 Oct; 28(10):1267-74. PubMed ID: 26313542 [TBL] [Abstract][Full Text] [Related]
25. Diffusion Kurtosis Imaging Detects Microstructural Changes in a Methamphetamine-Induced Mouse Model of Parkinson's Disease. Arab A; Ruda-Kucerova J; Minsterova A; Drazanova E; Szabó N; Starcuk Z; Rektorova I; Khairnar A Neurotox Res; 2019 Nov; 36(4):724-735. PubMed ID: 31209787 [TBL] [Abstract][Full Text] [Related]
28. White matter alterations in Parkinson's disease with levodopa-induced dyskinesia. Ogawa T; Hatano T; Kamagata K; Andica C; Takeshige-Amano H; Uchida W; Saito Y; Shimo Y; Oyama G; Umemura A; Iwamuro H; Ito M; Hori M; Aoki S; Hattori N Parkinsonism Relat Disord; 2021 Sep; 90():8-14. PubMed ID: 34325387 [TBL] [Abstract][Full Text] [Related]
29. Case control study of diffusion tensor imaging in Parkinson's disease. Chan LL; Rumpel H; Yap K; Lee E; Loo HV; Ho GL; Fook-Chong S; Yuen Y; Tan EK J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1383-6. PubMed ID: 17615165 [TBL] [Abstract][Full Text] [Related]
30. Brain microstructural alterations in type 2 diabetes: diffusion kurtosis imaging provides added value to diffusion tensor imaging. Xiong Y; Sui Y; Zhang S; Zhou XJ; Yang S; Fan Y; Zhang Q; Zhu W Eur Radiol; 2019 Apr; 29(4):1997-2008. PubMed ID: 30338363 [TBL] [Abstract][Full Text] [Related]
31. Structural changes in Parkinson's disease: voxel-based morphometry and diffusion tensor imaging analyses based on Kikuchi K; Hiwatashi A; Togao O; Yamashita K; Somehara R; Kamei R; Baba S; Yamaguchi H; Kira JI; Honda H Eur Radiol; 2017 Dec; 27(12):5073-5079. PubMed ID: 28677058 [TBL] [Abstract][Full Text] [Related]
35. Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging. Zhan W; Kang GA; Glass GA; Zhang Y; Shirley C; Millin R; Possin KL; Nezamzadeh M; Weiner MW; Marks WJ; Schuff N Mov Disord; 2012 Jan; 27(1):90-7. PubMed ID: 21850668 [TBL] [Abstract][Full Text] [Related]
36. Neuroimaging abnormalities in individuals exhibiting Parkinson's disease risk markers. Heldmann M; Heeren J; Klein C; Rauch L; Hagenah J; Münte TF; Kasten M; Brüggemann N Mov Disord; 2018 Sep; 33(9):1412-1422. PubMed ID: 29756356 [TBL] [Abstract][Full Text] [Related]
37. Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease. Kim HJ; Kim SJ; Kim HS; Choi CG; Kim N; Han S; Jang EH; Chung SJ; Lee CS Neurosci Lett; 2013 Aug; 550():64-8. PubMed ID: 23831353 [TBL] [Abstract][Full Text] [Related]
38. Diffusion Kurtosis Imaging of Microstructural Changes in Gray Matter Nucleus in Parkinson Disease. Bingbing G; Yujing Z; Yanwei M; Chunbo D; Weiwei W; Shiyun T; Yangyingqiu L; Jin S; Qingwei S; Ailian L; Lizhi X Front Neurol; 2020; 11():252. PubMed ID: 32362865 [No Abstract] [Full Text] [Related]